amiodarone has been researched along with A-V Dissociation in 49 studies
Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Poisoning with flecainide acetate is rare and associated with a high mortality." | 8.80 | [Severe flecainide acetate poisoning. Apropos of a case]. ( Chevrolet, JC; Elamly, A; Maury, P; Metzger, J; Schoenenberger, I; Veragut, B; Vuille, C, 1999) |
| "Amiodarone is an effective antiarrhythmic drug rarely associated with torsade de pointes arrhythmias (TdP)." | 7.71 | Chronic amiodarone evokes no torsade de pointes arrhythmias despite QT lengthening in an animal model of acquired long-QT syndrome. ( de Groot, SH; Leunissen, JD; Molenschot, MM; Schoenmakers, M; van Der Hulst, FF; van Opstal, JM; Verduyn, SC; Vos, MA; Wellens, HJ, 2001) |
| "We have assessed the ability of the new amiodarone-like antiarrhythmic agent, SR 33589, to reduce the incidence of ischemia- and reperfusion-induced arrhythmias, in comparison to amiodarone, D-sotalol, and lignocaine." | 7.69 | SR 33589, a new amiodarone-like agent: effect on ischemia- and reperfusion-induced arrhythmias in anesthetized rats. ( Bruyninckx, C; Chatelain, P; Manning, AS; Ramboux, J, 1995) |
| "A 65-year-old man with paroxysmal atrial flutter was treated with digoxin and flecainide." | 7.68 | 1:1 atrioventricular conduction in atrial flutter with digoxin and flecainide. ( Ahsan, A; Aldridge, R; Bowes, R, 1993) |
| "We observed sinoatrial block due to chronic amiodarone administration in a 5-year-old boy with primary cardiomyopathy, Wolff-Parkinson-White syndrome and supraventricular tachycardia." | 7.67 | Amiodarone-induced sinoatrial block. ( Berand, M; Davidson, E; Strasberg, B, 1985) |
| "Amiodarone has been shown to improve survival in patients with impaired left ventricular function and ventricular trachyarrhythmias." | 5.29 | [Symptomatic bradycardia with amiodarone in patients with pre-existing conduction disorders]. ( Hofmann, R; Leisch, F, 1995) |
| "TWelve patients had overt congestive heart failure." | 5.27 | Intravenous amiodarone in the acute treatment of recurrent symptomatic ventricular tachycardia. ( DiCarlo, L; Morady, F; Scheinman, MM; Shapiro, W; Shen, E; Sung, RJ, 1983) |
| " Electrophysiologic data obtained before and during thyroxine replacement therapy showed that hypothyroidism lengthens the effective refractory period of the atria, AV node, bypass tract and His-Purkinje system (that in the ventricle not being measured); this lengthening resembles the effects of long-term administration of amiodarone." | 5.27 | Atrioventricular block complicating amiodarone-induced hypothyroidism in a patient with pre-excitation and rate-dependent bilateral bundle branch block. ( Brun, S; Gaita, F; Mangiardi, L; Nademanee, K; Presbitero, P; Singh, BN, 1986) |
| "Poisoning with flecainide acetate is rare and associated with a high mortality." | 4.80 | [Severe flecainide acetate poisoning. Apropos of a case]. ( Chevrolet, JC; Elamly, A; Maury, P; Metzger, J; Schoenenberger, I; Veragut, B; Vuille, C, 1999) |
| " The incidence of clinical torsade de pointes (TdP) associated with amiodarone has been reported to be low and the present study compared the proarrhythmic potential of amiodarone with that of a selective IKr channel blocker, sematilide, using a canine chronic atrioventrucular block model." | 3.71 | Comparison of the in vivo electrophysiological and proarrhythmic effects of amiodarone with those of a selective class III drug, sematilide, using a canine chronic atrioventricular block model. ( Hashimoto, K; Ishida, Y; Kugiyama, K; Satoh, Y; Sugiyama, A; Yoneyama, M; Yoshida, H, 2002) |
| "Amiodarone is an effective antiarrhythmic drug rarely associated with torsade de pointes arrhythmias (TdP)." | 3.71 | Chronic amiodarone evokes no torsade de pointes arrhythmias despite QT lengthening in an animal model of acquired long-QT syndrome. ( de Groot, SH; Leunissen, JD; Molenschot, MM; Schoenmakers, M; van Der Hulst, FF; van Opstal, JM; Verduyn, SC; Vos, MA; Wellens, HJ, 2001) |
| "We have assessed the ability of the new amiodarone-like antiarrhythmic agent, SR 33589, to reduce the incidence of ischemia- and reperfusion-induced arrhythmias, in comparison to amiodarone, D-sotalol, and lignocaine." | 3.69 | SR 33589, a new amiodarone-like agent: effect on ischemia- and reperfusion-induced arrhythmias in anesthetized rats. ( Bruyninckx, C; Chatelain, P; Manning, AS; Ramboux, J, 1995) |
| "A 65-year-old man with paroxysmal atrial flutter was treated with digoxin and flecainide." | 3.68 | 1:1 atrioventricular conduction in atrial flutter with digoxin and flecainide. ( Ahsan, A; Aldridge, R; Bowes, R, 1993) |
| "Two patients, one with and one without preexisting conduction system abnormalities, were treated with amiodarone for refractory ventricular arrhythmias." | 3.67 | Amiodarone-induced intra-His block. ( Batsford, WP; Kennedy, EE, 1984) |
| " Individual differences between the longest and the shortest RV MAP durations indicate that: normally (40 subjects) ventricular repolarization is almost synchronous; QT prolongation due either to bradycardia or to amiodarone treatment (eight cases) may be the result of a uniform lengthening of ventricular repolarization, when ventricular arrhythmias are not present; in long QT syndromes (LQTSs) of differing etiology (10 cases), in which severe ventricular arrhythmias are present, marked individual differences in RV MAP duration are present and correspond with pathological asynchrony of ventricular repolarization." | 3.67 | Monophasic action potential studies in human subjects with prolonged ventricular repolarization and long QT syndromes. ( Bonatti, V; Botti, G; Rolli, A, 1985) |
| "A patient with sick sinus syndrome and resistant paroxysmal atrial flutter was treated with amiodarone and implanted with a Medtronic 7005 DDD pacemaker." | 3.67 | Noninvasive conversion of atrial flutter using a multiprogrammable DDD pulse generator. ( Castellanos, A; Luceri, RM; Myerburg, RJ; Thurer, RJ, 1986) |
| "We observed sinoatrial block due to chronic amiodarone administration in a 5-year-old boy with primary cardiomyopathy, Wolff-Parkinson-White syndrome and supraventricular tachycardia." | 3.67 | Amiodarone-induced sinoatrial block. ( Berand, M; Davidson, E; Strasberg, B, 1985) |
| "Amiodarone was given intravenously over 30 seconds in a dose of 300 mg; in 15 of the patients a further dose of 150 mg was given after ten minutes." | 2.64 | [Anti-arrhythmic effects of injectable amiodarone. Apropos of 100 cases]. ( Benaim, R; Chapelle, M; Chiche, P; Denizeau, JP; Domengie, B; Kolsky, H; Melon, J, 1976) |
| "Amiodarone is a highly effective antiarrhythmic agent." | 2.40 | [Follow-up of patients treated by amiodarone]. ( Kulbertus, H; Lancellotti, P; Mélon, P, 1998) |
| "Amiodarone was administered orally in a dose of 200 mg/body per day for the initial 7 days followed by 100 mg for the following 21 days (n = 7)." | 1.34 | In vivo electropharmacological effects of amiodarone and candesartan on atria of chronic atrioventricular block dogs. ( Aonuma, K; Matsumoto, M; Nakamura, Y; Sugiyama, A; Takahara, A; Wang, K, 2007) |
| "Pharmacological treatment of the supraventricular tachycardia solved the problem." | 1.32 | Inappropriate single chamber ICD discharges due to supraventricular tachycardia with high degree atrioventricular block. ( De Palma, C; Kreutzer, E; Scaglione, J; Socas, AG, 2004) |
| "In amiodarone-treated, hypokalemic hearts, no EAD or TdP occurred." | 1.32 | Comparison of the in vitro electrophysiologic and proarrhythmic effects of amiodarone and sotalol in a rabbit model of acute atrioventricular block. ( Breithardt, G; Eckardt, L; Haverkamp, W; Milberg, P; Mönnig, G; Osada, N; Ramtin, S; Wasmer, K, 2004) |
| "Amiodarone has been shown to improve survival in patients with impaired left ventricular function and ventricular trachyarrhythmias." | 1.29 | [Symptomatic bradycardia with amiodarone in patients with pre-existing conduction disorders]. ( Hofmann, R; Leisch, F, 1995) |
| "TWelve patients had overt congestive heart failure." | 1.27 | Intravenous amiodarone in the acute treatment of recurrent symptomatic ventricular tachycardia. ( DiCarlo, L; Morady, F; Scheinman, MM; Shapiro, W; Shen, E; Sung, RJ, 1983) |
| " Electrophysiologic data obtained before and during thyroxine replacement therapy showed that hypothyroidism lengthens the effective refractory period of the atria, AV node, bypass tract and His-Purkinje system (that in the ventricle not being measured); this lengthening resembles the effects of long-term administration of amiodarone." | 1.27 | Atrioventricular block complicating amiodarone-induced hypothyroidism in a patient with pre-excitation and rate-dependent bilateral bundle branch block. ( Brun, S; Gaita, F; Mangiardi, L; Nademanee, K; Presbitero, P; Singh, BN, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 23 (46.94) | 18.7374 |
| 1990's | 9 (18.37) | 18.2507 |
| 2000's | 13 (26.53) | 29.6817 |
| 2010's | 4 (8.16) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bardien-Kruger, S | 1 |
| Wulff, H | 1 |
| Arieff, Z | 1 |
| Brink, P | 1 |
| Chandy, KG | 1 |
| Corfield, V | 1 |
| Sato, Y | 1 |
| Dohi, K | 1 |
| Kusuki, H | 1 |
| Tanimura, M | 1 |
| Watanabe, K | 1 |
| Sugiura, E | 1 |
| Kumagai, N | 1 |
| Nakamori, S | 1 |
| Nakajima, H | 1 |
| Fujii, E | 1 |
| Nakamura, M | 1 |
| Nobori, T | 1 |
| Ito, M | 1 |
| Alexandre, J | 1 |
| Rouet, R | 1 |
| Puddu, PE | 1 |
| Beygui, F | 1 |
| Manrique, A | 1 |
| Milliez, P | 1 |
| Jackson, MW | 1 |
| Taylor, RJ | 1 |
| Spragg, DD | 1 |
| Marine, JE | 1 |
| Yoshida, H | 1 |
| Sugiyama, A | 2 |
| Satoh, Y | 1 |
| Ishida, Y | 1 |
| Yoneyama, M | 1 |
| Kugiyama, K | 1 |
| Hashimoto, K | 1 |
| Seniuk, W | 1 |
| Mularek-Kubzdela, T | 1 |
| Grygier, M | 1 |
| Grajek, S | 1 |
| Cieśliński, A | 1 |
| McMahon, CJ | 1 |
| Laird, WP | 1 |
| Fenrich, AL | 1 |
| Kautzner, J | 1 |
| Cihá, R | 1 |
| Peichl, P | 1 |
| Nogami, A | 1 |
| Tada, H | 1 |
| Naito, S | 1 |
| Kaneko, T | 1 |
| Scaglione, J | 1 |
| Socas, AG | 1 |
| De Palma, C | 1 |
| Kreutzer, E | 1 |
| Milberg, P | 1 |
| Ramtin, S | 1 |
| Mönnig, G | 1 |
| Osada, N | 1 |
| Wasmer, K | 1 |
| Breithardt, G | 1 |
| Haverkamp, W | 1 |
| Eckardt, L | 1 |
| Wang, K | 1 |
| Takahara, A | 1 |
| Nakamura, Y | 1 |
| Aonuma, K | 1 |
| Matsumoto, M | 1 |
| Morady, F | 1 |
| Scheinman, MM | 1 |
| Shen, E | 1 |
| Shapiro, W | 1 |
| Sung, RJ | 1 |
| DiCarlo, L | 1 |
| Vergara, G | 1 |
| Disertori, M | 1 |
| Inama, G | 1 |
| Guarnerio, M | 1 |
| Bettini, R | 1 |
| Durante, G | 1 |
| Stirpe, E | 1 |
| Furlanello, F | 1 |
| Meulendyk, J | 1 |
| Kennedy, EE | 1 |
| Batsford, WP | 1 |
| Gallagher, JD | 1 |
| Lieberman, RW | 1 |
| Meranze, J | 1 |
| Spielman, SR | 1 |
| Ellison, N | 1 |
| Marcus, FI | 1 |
| Fontaine, GH | 1 |
| Frank, R | 1 |
| Grosgogeat, Y | 1 |
| Santinelli, V | 1 |
| Chiariello, M | 1 |
| Ambrosio, G | 1 |
| Stanislao, M | 1 |
| Condorelli, M | 2 |
| Critelli, G | 1 |
| Gallagher, JJ | 1 |
| Perticone, F | 1 |
| Monda, V | 1 |
| Coltorti, F | 1 |
| Wellens, HJ | 2 |
| Bär, FW | 1 |
| Dassen, WR | 1 |
| Brugada, P | 1 |
| Vanagt, EJ | 1 |
| Farré, J | 1 |
| Heric, B | 1 |
| Lytle, BW | 1 |
| Miller, DP | 1 |
| Rosenkranz, ER | 1 |
| Lever, HM | 1 |
| Cosgrove, DM | 1 |
| Sainte-Beuve, C | 1 |
| Victor, J | 1 |
| Penisson, I | 1 |
| Tadei, A | 1 |
| Terada, Y | 1 |
| Mitsui, T | 1 |
| Yamaguchi, I | 1 |
| Ahsan, A | 1 |
| Aldridge, R | 1 |
| Bowes, R | 1 |
| Hofmann, R | 1 |
| Leisch, F | 1 |
| Manning, AS | 1 |
| Bruyninckx, C | 1 |
| Ramboux, J | 1 |
| Chatelain, P | 1 |
| Lancellotti, P | 1 |
| Mélon, P | 1 |
| Kulbertus, H | 1 |
| Maury, P | 1 |
| Vuille, C | 1 |
| Metzger, J | 1 |
| Veragut, B | 1 |
| Schoenenberger, I | 1 |
| Elamly, A | 1 |
| Chevrolet, JC | 1 |
| Raviña, T | 1 |
| Gutierrez, J | 1 |
| Nkomo, VT | 1 |
| Shen, WK | 1 |
| van Opstal, JM | 1 |
| Schoenmakers, M | 1 |
| Verduyn, SC | 1 |
| de Groot, SH | 1 |
| Leunissen, JD | 1 |
| van Der Hulst, FF | 1 |
| Molenschot, MM | 1 |
| Vos, MA | 1 |
| Kochiadakis, GE | 1 |
| Skalidis, EI | 1 |
| Kalebubas, MD | 1 |
| Igoumenidis, NE | 1 |
| Chrysostomakis, SI | 1 |
| Kanoupakis, EM | 1 |
| Simantirakis, EN | 1 |
| Vardas, PE | 1 |
| Pucciarelli, G | 1 |
| Caso, P | 1 |
| Jacono, A | 1 |
| Boucher, M | 1 |
| Duchene-Marullaz, D | 1 |
| Benaim, R | 1 |
| Denizeau, JP | 1 |
| Melon, J | 1 |
| Domengie, B | 1 |
| Kolsky, H | 1 |
| Chapelle, M | 1 |
| Chiche, P | 1 |
| Rossi, A | 1 |
| Girotti, AL | 1 |
| Halpern, MS | 1 |
| Elizari, MV | 1 |
| Rosenbaum, MB | 1 |
| Rogers, JG | 1 |
| Windle, JR | 1 |
| McManus, BM | 1 |
| Easley, AR | 1 |
| Fananapazir, L | 1 |
| Rademaker, M | 1 |
| Bennett, DH | 1 |
| Bonatti, V | 1 |
| Rolli, A | 1 |
| Botti, G | 1 |
| Luceri, RM | 1 |
| Castellanos, A | 1 |
| Thurer, RJ | 1 |
| Myerburg, RJ | 1 |
| Bayés de Luna, A | 1 |
| Oter, MC | 1 |
| Guindo, J | 1 |
| Mangiardi, L | 1 |
| Gaita, F | 1 |
| Brun, S | 1 |
| Presbitero, P | 1 |
| Nademanee, K | 1 |
| Singh, BN | 1 |
| Ben-Chetrit, E | 1 |
| Ackerman, Z | 1 |
| Eliakim, M | 1 |
| Strasberg, B | 1 |
| Davidson, E | 1 |
| Berand, M | 1 |
| Di Giacomo, V | 1 |
| Tedeschi, A | 1 |
| Mammarella, G | 1 |
| di Giacomo, M | 1 |
| Liberman, BA | 1 |
| Teasdale, SJ | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Randomized Prospective Comparison of DDD Chamber Pacing and Percutaneous Transluminal Septal Ablation in Obstructive Hypertrophic Cardiomyopathy Associated With Severe Drug-Refractory Symptoms[NCT00001894] | Phase 2 | 70 participants | Interventional | 1999-08-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 reviews available for amiodarone and A-V Dissociation
| Article | Year |
|---|---|
Clinical pharmacology and therapeutic applications of the antiarrhythmic agent amiodarone.
Topics: Acute Disease; Administration, Oral; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atria | 1981 |
[Follow-up of patients treated by amiodarone].
Topics: Amiodarone; Anti-Arrhythmia Agents; Contraindications; Drug Interactions; Drug Monitoring; Follow-Up | 1998 |
[Severe flecainide acetate poisoning. Apropos of a case].
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Flutter; Biological Availability; Calcium Gluconate | 1999 |
2 trials available for amiodarone and A-V Dissociation
| Article | Year |
|---|---|
[Anti-arrhythmic effects of injectable amiodarone. Apropos of 100 cases].
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzofurans; Clinical Trials as Topi | 1976 |
Interatrial conduction block with retrograde activation of the left atrium and paroxysmal supraventricular tachyarrhythmias: influence of preventive antiarrhythmic treatment.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Electrocardiography; | 1989 |
44 other studies available for amiodarone and A-V Dissociation
| Article | Year |
|---|---|
Characterisation of the human voltage-gated potassium channel gene, KCNA7, a candidate gene for inherited cardiac disorders, and its exclusion as cause of progressive familial heart block I (PFHBI).
Topics: Amino Acid Sequence; Animals; Base Sequence; Cloning, Molecular; COS Cells; DNA; Heart Block; Heart | 2002 |
Heart failure exacerbation associated with newly developed atrioventricular dyssynchrony after chemical conversion to a sinus rhythm in a patient receiving cardiac resynchronization therapy.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Resynchronization Therapy; Defibril | 2013 |
Dronedarone versus amiodarone in preventing premature ventricular contractions in an in vitro model of "border zone".
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Dose-Response Relationship, Drug; Dronedarone; Electroc | 2014 |
New-Onset Heart Failure in a Patient With a Pacemaker: An Unusual Cause.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Aortic Valve Stenosis; Atrial Fibrillation; Bisoprolol; Ca | 2016 |
Inappropriate biventricular implantable cardioverter defibrillator firing due to cryptogenic double counting.
Topics: Amiodarone; Atrial Fibrillation; Defibrillators, Implantable; Heart Block; Humans; Male; Middle Aged | 2010 |
Comparison of the in vivo electrophysiological and proarrhythmic effects of amiodarone with those of a selective class III drug, sematilide, using a canine chronic atrioventricular block model.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Chronic Disease; Dogs; Dose-Respo | 2002 |
Cardiac arrest related to coronary spasm in patients with variant angina: a three-case study.
Topics: Amiodarone; Angina Pectoris, Variant; Anti-Arrhythmia Agents; Aspirin; Calcium Channel Blockers; Car | 2002 |
Amiodarone-induced 2 to 1 atrioventricular block in association with prolongation of the QT interval.
Topics: Amiodarone; Anti-Arrhythmia Agents; Heart Block; Heart Conduction System; Humans; Infant, Newborn; M | 2003 |
Double potentials as a criterion for cavotricuspid isthmus block?
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Aged; Amiodarone; Atrial Flutter; Drug Synerg | 2004 |
Unidirectional atrio-atrial conduction after surgical isolation of the posterior part of the left atrium and pulmonary veins for atrial fibrillation: simple postsurgical procedure electrophysiological evaluation.
Topics: Adenosine Triphosphate; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cryosurgery; | 2004 |
Inappropriate single chamber ICD discharges due to supraventricular tachycardia with high degree atrioventricular block.
Topics: Adolescent; Amiodarone; Anti-Arrhythmia Agents; Defibrillators, Implantable; Electrocardiography; Eq | 2004 |
Comparison of the in vitro electrophysiologic and proarrhythmic effects of amiodarone and sotalol in a rabbit model of acute atrioventricular block.
Topics: Action Potentials; Administration, Oral; Amiodarone; Animals; Disease Models, Animal; Drug Administr | 2004 |
In vivo electropharmacological effects of amiodarone and candesartan on atria of chronic atrioventricular block dogs.
Topics: Amiodarone; Angiotensin II Type 1 Receptor Blockers; Animals; Anti-Arrhythmia Agents; Benzimidazoles | 2007 |
Intravenous amiodarone in the acute treatment of recurrent symptomatic ventricular tachycardia.
Topics: Adult; Aged; Amiodarone; Benzofurans; Female; Heart Block; Heart Failure; Humans; Infusions, Parente | 1983 |
[Sustained ventricular tachycardia: induced polymorphism. Clinical and electrophysiological aspects; therapeutic implications].
Topics: Adult; Aged; Ajmaline; Amiodarone; Electric Stimulation; Electrocardiography; Electrophysiology; Fem | 1984 |
Anesthetic considerations with amiodarone: report of a case.
Topics: Aged; Amiodarone; Anesthesia, General; Benzofurans; Bradycardia; Coronary Artery Bypass; Heart Block | 1984 |
Amiodarone-induced intra-His block.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Atrioventricular Node; Benzofurans; Bundle of His; Electroca | 1984 |
Amiodarone-induced complications during coronary artery surgery.
Topics: Amiodarone; Benzofurans; Coronary Artery Bypass; Heart Block; Humans; Male; Middle Aged; Postoperati | 1981 |
Further observations on the electrophysiologic effects of oral amiodarone therapy.
Topics: Adult; Amiodarone; Benzofurans; Heart Block; Heart Conduction System; Humans; Male | 1982 |
[Closed chest interruption of A-V conduction in the treatment of refractory supraventricular tachyarrhythmias. A clinical contribution].
Topics: Amiodarone; Atrial Fibrillation; Atrial Flutter; Cardiac Pacing, Artificial; Digitalis Glycosides; E | 1982 |
Effect of drugs in the Wolff-Parkinson-White syndrome. Importance of initial length of effective refractory period of the accessory pathway.
Topics: Accessory Nerve; Adolescent; Adult; Ajmaline; Amiodarone; Child; Female; Heart Block; Humans; Male; | 1980 |
Surgical management of hypertrophic obstructive cardiomyopathy. Early and late results.
Topics: Aged; Aged, 80 and over; Amiodarone; Cardiomyopathy, Hypertrophic; Chi-Square Distribution; Coronary | 1995 |
[Arrhythmia and conduction defects in polymyositis].
Topics: Adult; Amiodarone; Arrhythmias, Cardiac; Dermatomyositis; Electrocardiography; Electrophysiology; Fo | 1994 |
Conduction disturbances after open heart operation in a patient receiving amiodarone.
Topics: Amiodarone; Atrial Fibrillation; Female; Heart Block; Heart Valve Prosthesis; Humans; Middle Aged; P | 1994 |
1:1 atrioventricular conduction in atrial flutter with digoxin and flecainide.
Topics: Aged; Amiodarone; Atrial Flutter; Atrioventricular Node; Digoxin; Drug Therapy, Combination; Electro | 1993 |
[Symptomatic bradycardia with amiodarone in patients with pre-existing conduction disorders].
Topics: Aged; Amiodarone; Bradycardia; Bundle-Branch Block; Dose-Response Relationship, Drug; Drug Administr | 1995 |
SR 33589, a new amiodarone-like agent: effect on ischemia- and reperfusion-induced arrhythmias in anesthetized rats.
Topics: Administration, Oral; Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzofurans | 1995 |
Amiodarone-induced AV block and ventricular standstill. A forme fruste of an idiopathic long QT syndrome.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Drug Therapy, Combination; Electrocardiography; Electrophy | 2000 |
Amiodarone-induced long QT and polymorphic ventricular tachycardia.
Topics: Action Potentials; Age Factors; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cathe | 2001 |
Chronic amiodarone evokes no torsade de pointes arrhythmias despite QT lengthening in an animal model of acquired long-QT syndrome.
Topics: Action Potentials; Administration, Oral; Amiodarone; Anesthesia; Animals; Anti-Arrhythmia Agents; Ar | 2001 |
Effect of acute atrial fibrillation on phasic coronary blood flow pattern and flow reserve in humans.
Topics: Acute Disease; Adenosine; Adult; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Fun | 2002 |
[Amiodarone and the thyroid gland: apropos of 2 cases of hypothyroidism].
Topics: Adult; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Female; Heart Block; Humans; Hypothyroidism; M | 1978 |
Comparative effects of amiodarone, perhexiline and bepridil on the cardiac rhythms of the unanesthetized dog in chronic heart block.
Topics: Amines; Amiodarone; Animals; Benzofurans; Benzylamines; Dogs; Female; Heart Block; Heart Rate; Male; | 1978 |
[2nd-degree atrio-ventricular block during treatment with amiodarone].
Topics: Aged; Amiodarone; Benzofurans; Electrocardiography; Female; Heart Block; Humans | 1977 |
Electrophysiologic and pharmacologic studies in a patient with acute myocardial infarction complicated by intraventricular and atrioventricular block.
Topics: Amiodarone; Bundle-Branch Block; Electrocardiography; Electrophysiology; Heart Block; Heart Conducti | 1975 |
Aspergillus myocarditis presenting as myocardial infarction with complete heart block.
Topics: Aged; Amiodarone; Aspergillosis; Aspergillus flavus; Heart; Heart Block; Humans; Lung Diseases; Male | 1990 |
Reliability of the evoked response in determining the paced ventricular rate and performance of the QT or rate responsive (TX) pacemaker.
Topics: Adolescent; Adult; Aged; Amiodarone; Atenolol; Cardiac Pacing, Artificial; Electrocardiography; Exer | 1985 |
Monophasic action potential studies in human subjects with prolonged ventricular repolarization and long QT syndromes.
Topics: Adolescent; Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Bradycardia; Cardiac Complexes, Premature | 1985 |
Noninvasive conversion of atrial flutter using a multiprogrammable DDD pulse generator.
Topics: Amiodarone; Atrial Flutter; Combined Modality Therapy; Electrocardiography; Heart Block; Heart Rate; | 1986 |
Atrioventricular block complicating amiodarone-induced hypothyroidism in a patient with pre-excitation and rate-dependent bilateral bundle branch block.
Topics: Amiodarone; Benzofurans; Bundle-Branch Block; Electrocardiography; Electrophysiology; Female; Heart | 1986 |
Amiodarone-associated hypothyroidism--a possible cause of digoxin intoxication.
Topics: Aged; Amiodarone; Benzofurans; Bradycardia; Digoxin; Drug Interactions; Electrocardiography; Female; | 1985 |
Amiodarone-induced sinoatrial block.
Topics: Amiodarone; Benzofurans; Cardiomyopathies; Child, Preschool; Dose-Response Relationship, Drug; Elect | 1985 |
[Grade II intermittent atrioventricular block during therapy with amiodarone. Dynamic Holter electrocardiographic study].
Topics: Aged; Amiodarone; Benzofurans; Electrocardiography; Heart Block; Humans; Male | 1985 |
Anaesthesia and amiodarone.
Topics: Adult; Aged; Amiodarone; Anesthesia, General; Anesthetics; Atropine; Benzofurans; Bradycardia; Cardi | 1985 |